IMPROVED ACCESS TO TECHNOLOGY NEEDED FOR PEOPLE WITH TYPE 2 DIABETES NEEDING INSULIN National Diabetes Services Scheme (NDSS) disparity in subsidised access to CGM systems
Australian Health Journal segment
Filmed in Canberra | March 2025
With
Susan Davidson, CEO
Australian Diabetes Educators Association
Sahar Awais,
NSW Registered Nurse
Susan Davidson is the CEO of the Australian Diabetes Educators Association (ADEA), the leading body for diabetes education in Australia. ADEA plays a crucial role in accrediting credentialed diabetes educators and providing essential training for all health professionals, as roughly 25% of individuals seeking healthcare are affected by diabetes.
In Australia, around 1.5 million people are diagnosed with diabetes, with an additional estimated 500,000 undiagnosed cases of Type 2 diabetes. Among those diagnosed, approximately 140,000 have Type 1 diabetes, while 1.3 million live with Type 2 diabetes, and about 65% of these individuals use insulin. The increasing prevalence of diabetes highlights the need for consistent education among healthcare providers to aid patients in managing their conditions effectively.
To address the evolving nature of diabetes management and technology, ADEA has recently introduced micro-credentials for healthcare professionals, enhancing their understanding of diabetes care. Consistent messaging from various healthcare providers is vital, as conflicting information can lead to patient confusion and disengagement from care.
The National Diabetes Services Scheme (NDSS) provides subsidised products for diabetes management; however, disparities exist in access to technology between those with Type 1 and Type 2 diabetes. While continuous glucose monitoring (CGM) devices are subsidised for Type 1, they are not available for Type 2 diabetes. ADEA advocates for equitable access to these essential tools, emphasising that all individuals with diabetes deserve the resources necessary for optimal management and reduced risk of complications. Without such technologies, many are forced to rely on finger pricking, which can be inconvenient and unsafe in settings such as the workplace and in higher education.
Source: Rewritten from transcript
-
Mission to raise awareness of sarcoma and need for clinical trial funding
Sarcoma, a rare and aggressive cancer, remains the deadliest cancer for children and young adults, accounting for nearly one third (30%) of cancer-related deaths among those aged 15–24 and one tenth (10%) of those aged 0–14. Further, still severely under-diagnosed, sarcoma only accounts for one sixth (15%) of all cancer diagnoses in the 15 – 24 age group, and less than a tenth (8%) among children under 10.
-
Connected Health Systems
Challenges in health care delivery have compounded, with clinical staff being exposed to the Omicron COVID variant. Reduced staffing has brought on its challenges to most already-strained state health care systems and the people working in them.
However, over the past 2 years of the pandemic, technology has played an increasing role on the front end for patients and consumers at home and clinicians in the medical setting. Much more is planned in technology that will deliver efficiency, reduce risk and make available new models of care. This has the potential to touch the working lives of all stakeholders and recipients of care.
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia
